Live Cases, Edited Cases and Lunch Symposiums Sponsored by the Industry

The participation of the medical industry is, undoubtedly, one of the most appealing aspects of the SOLACI-SOCIME 2018 Congress. As usual, the most important companies in this industry have decided to take part in our event. Their contribution is most valuable, as it brings relevance and improves the quality of our scientific presentations. Organize your schedule featuring the best live cases, edited cases and industry-sponsored symposiums!

Conferencias Magistrales

Live cases

August 1st | 09.45h – 11.00h | Main arena

WIN@SOLACI Live Cases from Instituto Nacional de Cardiología (INC) TERUMO and OCCLUTECH-SIEMENS HEALTHINEERS

 

August 1st | 15.00h – 16.30h | Main Arena 

Live Cases from Instituto Nacional de Cardiología (INC) PHILIPS-EDWARDS

 

August 2nd | 09.45h – 11.00h | Main Arena 

Live Cases 5 and 6 from Hospital 20 de Noviembre. MEDTRONIC

 

August 2nd | 15.00h – 16.30h | Main Arena 

Live Cases SOLACI-SOCIME from Hospital 20 de Noviembre

 

August 3rd | 09.45h – 11.00h | Main Arena 

Live Cases from CMN Siglo XXI. Medtronic and Philips

 

August 3rd | 15.00h – 16.30h | Main Arena 

Live Cases SOLACI-SOCIME from CMN La Raza

 

Edited cases

August 1st | 11.10h – 12.25h | Cases room 

11:10h-11:25h – MICROPORT Case

11:25h-11:40h – Lifetech Case

11:40h-11:55h – IHT Case

 

Sponsored Lunch Symposiums

August 1st | 13.30h – 15.00h | Main arena

Lunch Symposium Sponsored by ABBOTT: “Mitral Valve Disease”

 

August 1st | 13.30h – 15.00h | Coronary room

Lunch Symposium Sponsored by ABBOTT: “CTO in my Clinic: a Starting Point”

 

August 1st | 13.30h – 15.00h | Pediatric Room

Lunch Symposium Sponsored by DDM: “20 years of Amplatzer in Mexico and Latin America

 

August 2nd | 13.30h – 15.00h | Main arena

Lunch Symposium Sponsored by ABBOTT: “Challenging Interventionism”

 

August 2nd | 13.30h – 15.00h | Coronary room

Lunch Symposium Sponsored by TERUMO: “Simplifying the complex by Radial”

 

August 2nd | 13.30h – 15.00h | Structural and peripheral room

Lunch Symposium Sponsored by PHILIPS: “Optimizing PCI results with iFR/FFR,IVUS and SyncVision”

 

August 2nd | 13.30h – 15.00h | Pediatric room 

Lunch Symposium Sponsored by OCCLUTECH “Occlutech Perfecting Performance”

 

August 3rd | 13.30h – 15.00h | Structural and peripheral room

Lunch Symposium Sponsored by BOSTON SCIENTIFIC

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....